The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Veterans Affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligometastatic prostate cancer (VA STARPORT).
 
Abhishek A Solanki
No Relationships to Disclose
 
Dara Campbell
No Relationships to Disclose
 
Kimberly Carlson
No Relationships to Disclose
 
Isla Garraway
No Relationships to Disclose
 
Elizabeth Henry
Employment - theMednet
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Other Relationship - theMednet
 
Jeffrey A Jones
No Relationships to Disclose
 
Thomas Koppes
No Relationships to Disclose
 
Caitlin Newman
No Relationships to Disclose
 
Marcus Lee Quek
No Relationships to Disclose
 
Matthew Rettig
Leadership - Aravalent; Survalent
Stock and Other Ownership Interests - Oncovalent Therapeutics; Survalent
Consulting or Advisory Role - Ambrx; Amgen; INMune Bio; Precisca; Roivant
Speakers' Bureau - Bayer; Johnson & Johnson
Research Funding - Arvinas (Inst); Fortis (Inst); Johnson & Johnson (Inst); Medivation/Astellas (Inst); Novartis (Inst); Progenics
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent for novel inhibitors of the N-terminal domain of the AR. There are NO commercial partnerships as of yet.
Travel, Accommodations, Expenses - Johnson & Johnson
 
Timothy Ritter
No Relationships to Disclose
 
Lisa Robin
No Relationships to Disclose
 
Joseph Kamel Salama
Consulting or Advisory Role - Bristol-Myers Squibb (I); Iovance Biotherapeutics (I); Novartis (I); Pfizer (I); Regeneron (I)
Research Funding - Ascentage Pharma (I); Bristol-Myers Squibb (I); Exact Sciences (Inst); IDEAYA Biosciences (I); Immunocore (I); Merck (I); Olatec (I); Replimune (I); Seagen (I)
 
Alicia Skipworth
No Relationships to Disclose
 
Elinore Zacny
No Relationships to Disclose
 
Kevin Zheng
No Relationships to Disclose
 
Nicholas George Nickols
Consulting or Advisory Role - Oncolinea Pharmaceuticals
Research Funding - Bayer (Inst); Janssen Scientific Affairs (Inst); Lantheus Medical Imaging (Inst); Progenics (Inst)
Patents, Royalties, Other Intellectual Property - I am listed as inventor on patents related to PyIm polyamides that have been licensed by Gene Sciences